Ananya Health, Inc. — SEC Form D Filing

Ananya Health, Inc. filed an SEC Form D on May 15, 2026, reporting $404K raised in Health Technology.

Form D filing details

Filing
SEC Form D
Filing date
May 15, 2026
Amount reported
$404K
Round stage
Seed
Industry
Health Technology
Website
https://www.ananya.health/

What the company does

Securities: Equity, SAFE. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Cervical cancer is a major cause of death among women, despite being more than 90% preventable. Many individuals lack access to early prevention technologies, and there are significant barriers to follow-up care after abnormal screenings.

Solution

Ananya Health is developing 'CRCL', a portable and easy-to-use cryoablation platform that allows treatment of pre-cancerous cells at the point of diagnosis in any clinic, overcoming the reliance on costly and bulky gas canisters.

Why now

There is an urgent need to prevent cervical cancer, especially as over 40 million individuals lack access to effective screening and treatment options.

Verdict

Investors backed Ananya Health at this moment primarily due to the pressing need for improved cervical cancer prevention technologies, betting on the potential of their novel cryoablation platform to disrupt existing care pathways. This cleared because the narrative highlighted urgent healthcare needs and presented a tangible solution, not because it fully elaborated on robust market structures or clear buyer engagement. However, the limited upside lies in the untested scalability of the solution beyond initial adoption, leaving uncertainties about long-term sustainability in a crowded health tech landscape.

Source: SEC EDGAR Form D filing